NIRS Monitoring in the NICU and AKI

Part of paid clinical trials in New York, New York.

Sponsor
NYU Langone Health
Study ID
NCT07222722
Status
Recruiting
Apply to this trial

Conditions

  • Acute Kidney Injury (AKI)
  • Postnatal AKI

Eligibility Criteria

Sex
ALL
Age
24 Weeks - 30 Weeks
Healthy Volunteers
Accepted

Interventions

  • NIRS Monitoring — DEVICE
    The renal NIRS device is a non-invasive tool that uses near-infrared light to measure oxygen saturation various tissues. Renal NIRS sensors will be placed by 24 hours of the participants' admission.

Study Details

The primary objective of this study is to describe the pattern of renal tissue oxygen saturation (SrSO2) using near-infrared spectroscopy (NIRS) in premature infants \<30 weeks gestational age. The secondary objective of this study is to evaluate prenatal and postnatal risk factors for acute kidney injury (AKI) in premature infants \<30 weeks gestational age. The investigators will also compare various rates of complications including death, length-of-stay, and prolonged duration of mechanical ventilation, among others.

Key Dates

Start date
Nov 30, 2025
Status verified
Oct 2025
Primary completion
Apr 1, 2026
Completion
Apr 1, 2026

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION

Arms

  • Experimental: NICU patients born less than 30 weeks gestational age
    All patients included in the study will be assigned to receive NIRS monitoring.

Primary Outcome Measure

Average NIRS Value (SrSO2) [ Time Frame: Up to Day-of-life 7 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NYU Langone HealthNew YorkNew York10016-

Find similar trials in New York, NY

By research site
NYU Langone Health· New York, NY

Related Studies